CD8A and neoplasm: An exploratory analysis of ABACUS trial data showed that highly CD8+ T cell-infiltrated tumours and the presence of a cytotoxic T cell transcriptional signature (tGE8) were associated with responses, whereas PD-L1 status and tumour mutational burden were not [54].